Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for purifying orlistat

A technology for orlistat and samples, which is applied in the field of preparing high-purity orlistat, and can solve problems such as inability to purify orlistat

Active Publication Date: 2006-04-26
HANGZHOU HUADONG MEDICINE GRP PHARMA RES INST
View PDF2 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention overcomes the defect that low-purity orlistat cannot be purified in the prior art, and provides a purification method that can purify low-purity orlistat to meet pharmaceutical standards and is suitable for industrial application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The fermentation extract concentrate contains lipstatin 30% (w / w) 120ml, and the sample is obtained after hydrogenation. It contains 46g orlistat sample, the content is 52%, and the sample color is about gray. Add 150ml of acetone to dissolve and filter, and add acetone to 600ml. After crystallization and suction filtration, 30 g of crystals were obtained, which was off-white, with a content of 96% (W / W) detected by HPLC, and the maximum impurity was 0.52%. Then add 120ml of acetone, dissolve, filter, add acetone to 400ml, crystallize at low temperature, and filter with suction to obtain 25g of crystals, off-white, detected by HPLC, content 97%, maximum impurity 0.4%. Add 500ml heptane to re-dissolve, filter, add heptane to 900ml, and crystallize to obtain 20g of orlistat pure product with a content of 98.8% and a maximum impurity of 0.4%.

Embodiment 2

[0029] The purity of the fermentation extract concentrate Lipstatin is 40% (weight / weight) 90ml, and the HPLC purity is 74% (calculated by the peak area normalization method). After hydrogenation, 52g of orlistat sample is obtained, the content is 68.9%, and the maximum impurity is 2.0%. 110ml of ethanol was dissolved, filtered, and supplemented with ethanol to 530ml, and crystallized to obtain 35g of orlistat sample with a purity of 83.1% and a maximum impurity of 0.9%. Add 550ml of heptane to re-dissolve, filter, add heptane to 1300ml, and crystallize to obtain 34g of orlistat sample with a purity of 88.1% and a maximum impurity of 0.9%. Add 700ml of heptane to re-dissolve, filter, add heptane to 1000ml, and crystallize to obtain 14g of orlistat pure product with a purity of 98.5% and the maximum impurity less than 0.5%.

Embodiment 3

[0031]The fermentation extract concentrate contains 100ml of lipstatin 35% (weight / weight), HPLC purity 71% (calculated by the peak area normalization method), after hydrogenation, about 51g of orlistat sample is obtained, the content is 70%, the sample color is gray, add 150ml of acetonitrile was dissolved, filtered, acetonitrile was added to 750ml, and crystallized to obtain 32g of orlistat sample, off-white, purity 91.1%, maximum impurity 0.92%; add 750ml of hexane to re-dissolve, filter, add hexane to 1400ml, Crystallized to obtain 31 g of orlistat sample with a purity of 93.5% and a maximum impurity of 0.92%. Add acetonitrile 65mi to dissolve, filter, add acetonitrile to 310mi, crystallize to obtain 18g of orlistat sample, off-white, purity 95.1%, maximum impurity 0.53%; add 270ml of hexane to redissolve, filter, add hexane to 420ml , Crystallized to obtain 16 g of orlistat pure product with a purity of 98.6% and a maximum impurity of less than 0.5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses orlistat purifying method, which includes dissolving coarse orlistate product in medium polarity solvent, filtering, eliminating impurity, crystallization, dissolving in non-polar solvent, recrystallization, and repeating some steps until reaching the medicinal purity standard. The said method is suitable for purifying coarse orlistate product with purity of 50-85 %, and has the advantages of high yield, short purification period, simple purification process and being suitable for industrial production.

Description

Technical field [0001] The present invention relates to a method for purifying organic compounds. Specifically, the present invention relates to a method for preparing high-purity orlistat. Background technique [0002] Orlistat is a hydrogenated derivative of the natural product of Streptomyces lipstatin (nipostatin), and its chemical name is (S)-2-formylamino-4-methyl-valerate ( S)-1-[[(2S, 3S,)-3-hexyl-4-oxo-2-oxetanyl]-methyl]-dodecyl ester. Orlistat is a specific gastrointestinal lipase inhibitor used to prevent and treat obesity-related diseases. [0003] The Chinese patent "Method for Purification of Pancreatin" (Publication No.: CN1266058A, published on September 13, 2000), discloses a method for purifying orlistat, which uses heptane for the lipatatin produced by the fermentation of Streptomyces Two-stream extraction is carried out with aqueous acetic acid, and hexane or heptane is used for hydrogenation and crystallization. The US patent leucine derivatives (patent numb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D305/12
Inventor 朱健陈晓霞
Owner HANGZHOU HUADONG MEDICINE GRP PHARMA RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com